| 发明名称 |
ABERRANT GLUTAMATE TRANSPORTERS AND METHODS OF USE |
| 摘要 |
In one aspect, the present invention features methods for detecting at least one neurological disorder in a patient, the method comprising obtaining a biological sample from the patient; and detecting at least one aberrant human glutamate transporter 2 (EAAT 2) mRNA in the sample as being indicative of the neurological disorder in the patient. In a particular aspect, the invention is useful for detecting amyotrophic lateral sclerosis (ALS) in the patient.
|
| 申请公布号 |
US2003060617(A1) |
申请公布日期 |
2003.03.27 |
| 申请号 |
US19980040736 |
申请日期 |
1998.03.18 |
| 申请人 |
LIN CHIENG-LIANG GLENN;BRISTOL LYNN A.;ROTHSTEIN JEFFERY D. |
发明人 |
LIN CHIENG-LIANG GLENN;BRISTOL LYNN A.;ROTHSTEIN JEFFERY D. |
| 分类号 |
C12Q1/68;(IPC1-7):G01N33/53;A01N43/04;A61K31/70;C07H21/02;C07H21/04;C12N1/20;C12N15/00;C12N15/09;C12N15/63;C12N15/70 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
